Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean Bennett

Showing results (151-160 of 175) with videos related to

Pageof 18
Sort By:
Investigative Ophthalmology & Visual Science|January 27, 2005
Disease expression in Usher syndrome caused by VLGR1 gene mutation (USH2C) and comparison with USH2A phenotypeSharon B Schwartz, Tomas S Aleman, Artur V Cideciyan, et al.
Investigative Ophthalmology & Visual Science|March 2, 2026
Combined Expression of hRdCVF and hRdCVFL Through AAV-Mediated Delivery for the Treatment of Retinitis PigmentosaEmmanuelle Clérin, Ying Yang, Delphine Pagan, et al.
Molecular Genetics and Metabolism|February 8, 2014
The Pex1-G844D mouse: a model for mild human Zellweger spectrum disorderShandi Hiebler, Tomohiro Masuda, Joseph G Hacia, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 20, 2005
Identifying photoreceptors in blind eyes caused by RPE65 mutations: Prerequisite for human gene therapy successSamuel G Jacobson, Tomas S Aleman, Artur V Cideciyan, et al.
Plos One|May 14, 2013
AAV-mediated gene therapy for choroideremia: preclinical studies in personalized modelsVidyullatha Vasireddy, Jason A Mills, Rajashekhar Gaddameedi, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 5, 2004
In utero gene therapy rescues vision in a murine model of congenital blindnessNadine S Dejneka, Enrico M Surace, Tomas S Aleman, et al.
Plos One|June 20, 2015
Correction: AAV-Mediated Gene Therapy for Choroideremia: Preclinical Studies in Personalized ModelsVidyullatha Vasireddy, Jason A Mills, Rajashekhar Gaddameedi, et al.
Experimental Eye Research|May 17, 2002
Macular pigment and lutein supplementation in choroideremiaJacque L Duncan, Tomas S Aleman, Leigh M Gardner, et al.
Ophthalmology|August 25, 2019
Efficacy, Safety, and Durability of Voretigene Neparvovec-rzyl in RPE65 Mutation-Associated Inherited Retinal Dystrophy: Results of Phase 1 and 3 TrialsAlbert M Maguire, Stephen Russell, Jennifer A Wellman, et al.
Human Molecular Genetics|February 21, 2012
Nxnl2 splicing results in dual functions in neuronal cell survival and maintenance of cell integrityCéline Jaillard, Aurélie Mouret, Marie-Laure Niepon, et al.
Pageof 18

Showing results (151-160 of 175) with videos related to

Sort By:
Pageof 18
Investigative Ophthalmology & Visual Science|January 27, 2005
Disease expression in Usher syndrome caused by VLGR1 gene mutation (USH2C) and comparison with USH2A phenotypeSharon B Schwartz, Tomas S Aleman, Artur V Cideciyan, et al.
Investigative Ophthalmology & Visual Science|March 2, 2026
Combined Expression of hRdCVF and hRdCVFL Through AAV-Mediated Delivery for the Treatment of Retinitis PigmentosaEmmanuelle Clérin, Ying Yang, Delphine Pagan, et al.
Molecular Genetics and Metabolism|February 8, 2014
The Pex1-G844D mouse: a model for mild human Zellweger spectrum disorderShandi Hiebler, Tomohiro Masuda, Joseph G Hacia, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 20, 2005
Identifying photoreceptors in blind eyes caused by RPE65 mutations: Prerequisite for human gene therapy successSamuel G Jacobson, Tomas S Aleman, Artur V Cideciyan, et al.
Plos One|May 14, 2013
AAV-mediated gene therapy for choroideremia: preclinical studies in personalized modelsVidyullatha Vasireddy, Jason A Mills, Rajashekhar Gaddameedi, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 5, 2004
In utero gene therapy rescues vision in a murine model of congenital blindnessNadine S Dejneka, Enrico M Surace, Tomas S Aleman, et al.
Plos One|June 20, 2015
Correction: AAV-Mediated Gene Therapy for Choroideremia: Preclinical Studies in Personalized ModelsVidyullatha Vasireddy, Jason A Mills, Rajashekhar Gaddameedi, et al.
Experimental Eye Research|May 17, 2002
Macular pigment and lutein supplementation in choroideremiaJacque L Duncan, Tomas S Aleman, Leigh M Gardner, et al.
Ophthalmology|August 25, 2019
Efficacy, Safety, and Durability of Voretigene Neparvovec-rzyl in RPE65 Mutation-Associated Inherited Retinal Dystrophy: Results of Phase 1 and 3 TrialsAlbert M Maguire, Stephen Russell, Jennifer A Wellman, et al.
Human Molecular Genetics|February 21, 2012
Nxnl2 splicing results in dual functions in neuronal cell survival and maintenance of cell integrityCéline Jaillard, Aurélie Mouret, Marie-Laure Niepon, et al.
Pageof 18